A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy
McLaughlin, Ronan P, He, Jichao, van der Noord, Vera E, Redel, Jevin, Foekens, John A, Martens, John W M, Smid, Marcel, Zhang, Yinghui, van de Water, Bob
Published in Breast cancer research : BCR (01.07.2019)
Published in Breast cancer research : BCR (01.07.2019)
Get full text
Journal Article
Abstract 103: Blockage of Cdc7/CDK9 signaling sensitizes triple negative breast cancer to EGFR-targeted therapy
McLaughlin, Ronan P., He, Jichao, Noord, Vera van der, Redel, Jevin, Smid, Marcel, Dorssers, Lambert, Martens, John, Foekens, John, Zhang, Yinghui, Water, Bob van de
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article